Biogen (BIIB) to Resume Trading at 7:10 a.m. After FDA Panel's Negative Vote on Potential Treatment for Alzheimer’s Disease

Biogen (NASDAQ: BIIB) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Next Articles